For citations:
Kim M.E., Murzagulova K.B., Stepanova E.F. ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT. Pharmacy & Pharmacology. 2016;4(3(16)):38-55. (In Russ.) https://doi.org/10.19163/2307-9266-2016-4-3-38-55
Email this article 